Clinical Trial Update: The Effect of Twice Daily vs. Once Daily Bronchodilation on Hyperinflation in COPD Patients During 24 Hours. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares twice-daily versus once-daily bronchodilation in COPD patients over 24 hours to assess impact on hyperinflation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Chronic Obstructive Airway Disease | Phase 4 | Status: UNKNOWN